Sleep Number experienced a challenging second quarter in 2025, with net sales dropping by 19.7% to $328 million and a net loss of $25 million, compared to a $5 million net loss in the prior year. Despite the sales decline, the company maintained its gross profit margin at 59.1% and successfully reduced operating expenses by 21% year-over-year, excluding restructuring costs. The company is undergoing a turnaround, implementing significant cost savings and new marketing and product initiatives.

Sleep Number reported a decrease in net sales and a net loss for the first quarter of 2025 compared to the prior year. However, the company improved its gross profit margin and reduced operating expenses through a new organizational structure and cost-saving initiatives.

Sleep Number reported Q4 2024 revenue of $377 million, a 12% decline year-over-year. The company posted a net loss of $5 million, a significant improvement from the $25 million loss in Q4 2023. Operating income turned positive at $2.8 million after cost reductions. Gross margin increased to 59.9% due to lower product costs and efficiency improvements.

Sleep Number's first quarter 2024 results showed a net sales of $470 million and an adjusted EBITDA of $37 million, slightly above expectations. The company reduced operating expenses by $24 million year-over-year and increased free cash flow by $21 million compared to the prior year's first quarter. They reiterated their full-year 2024 adjusted EBITDA outlook of $125 million to $145 million.

Sleep Number's Q4 2023 results showed a 14% decrease in net sales to $430 million, but gross margin improved by 190 bp to 56.6%. The company reduced operating expenses by $24 million and reported a loss per diluted share of $1.12, or an adjusted loss of $0.58 excluding restructuring costs. Full-year net sales decreased by 11% to $1.89 billion, with an adjusted loss per share of $0.14.

Sleep Number reported a challenging third quarter with a 13% decrease in net sales to $473 million due to an abrupt slowdown in consumer demand. The company initiated additional cost reduction actions and amended its credit agreement to navigate the challenging environment. They updated their full-year EPS outlook to a loss of up to $0.70 per share.

Sleep Number reported a decrease in net sales to $459 million, driven by a challenging macro environment. However, demand improved throughout the quarter. The company reported EPS of $0.03 and is taking actions to drive efficiencies and expand margins.

Sleep Number reported net sales of $527 million, consistent with the prior year. Net operating profit increased to $26 million, up $22 million versus the prior year. Diluted EPS was $0.51 compared to $0.09 last year. The company reiterates its full-year 2023 earnings outlook of $1.25 to $2.00 per diluted share.

Sleep Number's fourth-quarter net sales increased by 1% compared to the prior year, while full-year net sales decreased by 3%. The company reported a net loss per diluted share for the quarter, compared to a net income per diluted share in the previous year. The company is introducing next-generation smart beds beginning in the second quarter.

Sleep Number reported a decrease in net sales by 16% due to semiconductor chip supply constraints and softer consumer demand. However, the diluted EPS of $0.22 was ahead of expectations. The company revised its 2022 EPS outlook to $1.50 to $2.00 per diluted share.

Sleep Number Corporation reported a 13% increase in net sales to $549 million and a 75% increase in diluted EPS to $1.54 for the second quarter of 2022. The company updated its full-year 2022 diluted EPS outlook to a range of $3.00 to $4.00 per share.

Sleep Number announced record third quarter 2021 results with net sales growing 21% to $640 million and diluted EPS growing 24% to $2.22.

Sleep Number announced record second-quarter results with a 70% increase in net sales and EPS of $0.88. The company raised its full-year EPS outlook to at least $7.25, driven by strong demand for its 360 smart beds and operational efficiencies.

Sleep Number Corporation reported a strong first quarter in 2021, marked by a 20% increase in net sales to $568 million and a demand surge of over 30% year-over-year. The company's operating income rose by 45%, reaching 13.4% of net sales, and diluted earnings per share grew by 85% to a record $2.51. The company also raised its full-year 2021 EPS outlook to at least $6.50.

Sleep Number Corporation reported a strong fourth quarter with net sales increasing by 29% to $568 million and earnings per diluted share increasing by 167% to $2.19. The company's full-year net sales increased 9% to $1.86 billion, and diluted EPS increased 81% to $4.90.

Sleep Number announced record third quarter 2020 results, with net sales growing 12% to a record $531 million. Operating income grew 78% and diluted EPS grew 90% to a record $1.79. The company also provided a 2020 earnings outlook of approximately $4.00 per diluted share, a 48% increase versus full-year 2019.

Sleep Number reported a decrease in net sales by 20% compared to the previous year, but saw high-single digit demand growth in the last two months of the quarter. The company's gross profit rate decreased due to product mix changes and sales deleverage, while operating expenses were reduced. The company is not providing financial guidance due to the continued uncertainty related to COVID-19.

Sleep Number reported an 11% increase in net sales to $473 million and a 70% growth in diluted EPS to a record $1.36 in the first quarter of 2020. The company is managing challenges caused by the COVID-19 pandemic by executing more than $250 million of cost and capital deployment actions to support business continuity.

Sleep Number Corporation reported record fourth-quarter and full-year 2019 results. Net sales increased by 7% to $441 million, and earnings per diluted share were $0.82.